JPRN-UMIN000038675
Recruiting
N/A
Observation of changes in ocular findings before and after the use of the IL-4 and 13 antibody preparation dupilumab - dupilumab
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Keio University
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who have refused to provide clinical information to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Visual disturbances of patients following operatioHealth Condition 1: O- Medical and SurgicalCTRI/2023/03/050562GCS medical college and hospital
Terminated
N/A
Changes in ocular mucin expression due to contact lens wearACTRN12609000447257Institute for Eye Research30
Completed
N/A
Observation of changes in ocular structural and functional parameters before and after steep Trendelenburg positioning during robotic-assisted laparoscopic radical prostatectomy (RALP)prostatic cancerJPRN-UMIN000022492Department of Ophthalmology Aichi Medical University20
Active, Not Recruiting
Phase 1
A clinical trial on the changes in ocular signs and symptoms in patientswith ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops to Taptiqom® eye drops.Glaucoma or Ocular HypertensionMedDRA version: 18.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: PTClassification code 10074026Term: Exfoliation glaucomaSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2014-005273-37-DESanten Oy120
Active, Not Recruiting
Phase 1
A clinical trial on the changes in ocular signs and symptoms in patientswith ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops to Taptiqom® eye drops.Glaucoma or Ocular HypertensionMedDRA version: 17.1Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersMedDRA version: 17.1Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 17.1Level: PTClassification code 10074026Term: Exfoliation glaucomaSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2014-005273-37-FISanten Oy120